|
"pai h c"的相关文件
显示项目 11-15 / 15 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 大葉大學 |
2013-06 |
Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus : A randomized controlled trial.
|
Lin, R. T.;Pai, H. C.;Lee, Y. C.;Tzeng, C. Y.;Chang, C. H.;Hung, P. H.;Chen, Y. I;Hsu, Tai-Hao;Tsai, C. C.;Lin, J. G;Chang, S. L. |
| 中國醫藥大學 |
2010-03 |
Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues.
|
(Dong, Y.); (Shi, Q.); (Pai, H.C.); 彭婕妤(Chieh-Yu Peng); (Pan, S.L.); (Teng, C.M.); (Nakagawa-Goto K,); (Eva Y.-H. P. Lee,#); 李國雄(Lee, K.H.)* |
| 臺大學術典藏 |
2010 |
The indazole derivative YD-3 specifically inhibits thrombin-induced angiogenesis in vitro and in vivo
|
Peng, C.-Y.;Pan, S.-L.;Pai, H.-C.;Tsai, A.-C.;Guh, J.-H.;Chang, Y.-L.;Kuo, S.-C.;Lee, F.-Y.;Teng, C.-M.; JIH-HWA GUH; CHE-MING TENG |
显示项目 11-15 / 15 (共1页)
1
每页显示[10|25|50]项目
|
